Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivastigmine reversal of biperiden-induced memory impairment in healthy adults
NL-OMON31193Active, not recruiting
- Sponsor
- Maastricht University
- Start
- Jan 2008
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised trial of rivastigmine and biperiden (4 arms), sponsored by Maastricht University. Primary endpoints: Behavioral performance on verbal learning task, Behavioral performance on continuous recognition memory task and 2 more. Started Jan 2008; status: active, not recruiting.
02
Drugs
rivastigminebiperiden
Beyond the preview
Go deeper on NL-OMON31193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31193.